Cargando…

Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review

It is already well-known that visceral adipose tissue is inseparably related to the pathogenesis, activity, and general outcome of inflammatory bowel disease (IBD). We are getting closer and closer to the molecular background of this loop, finding certain relationships between activated mesenteric t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalak, Agata, Kasztelan-Szczerbińska, Beata, Cichoż-Lach, Halina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573343/ https://www.ncbi.nlm.nih.gov/pubmed/36235636 http://dx.doi.org/10.3390/nu14193983

Ejemplares similares

Wilson’s Disease: An Update on the Diagnostic Workup and Management
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2021)

Refractory ascites—the contemporary view on pathogenesis and therapy
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2019)

Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2023)

Oxidative Stress—A Key Player in the Course of Alcohol-Related Liver Disease
por: Michalak, Agata, et al.
Publicado: (2021)

Gender-related disparities in the frequencies of PD-1 and PD-L1 positive peripheral blood T and B lymphocytes in patients with alcohol-related liver disease: a single center pilot study
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2021)

A Rare Case of Upper Gastrointestinal Bleeding: Osler-Weber-Rendu Syndrome
por: Jargielo, Anna, et al.
Publicado: (2022)

Gullo’s syndrome – what do we know?
por: Rycyk, Anna, et al.
Publicado: (2020)

Blood concentrations of mediators released from activated neutrophils are related to the severity of alcohol-induced liver damage
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2023)

Angiogenesis-Related Biomarkers in Patients with Alcoholic Liver Disease: Their Association with Liver Disease Complications and Outcome
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2014)

A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis
por: Cichoż-Lach, Halina, et al.
Publicado: (2017)

A rare case of skin blistering and esophageal stenosis in the course of epidermolysis bullosa - case report and literature review
por: Michalak, Agata, et al.
Publicado: (2018)

Liver injury in the era of COVID-19
por: Cichoż-Lach, Halina, et al.
Publicado: (2021)

Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease
por: Michalak, Agata, et al.
Publicado: (2022)

Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients
por: Michalak, Agata, et al.
Publicado: (2021)

Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
por: Michalak, Agata, et al.
Publicado: (2020)

Deviations in Peripheral Blood Cell Populations are Associated with the Stage of Primary Biliary Cholangitis and Presence of Itching
por: Cichoż-Lach, Halina, et al.
Publicado: (2018)

Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences
por: Kasztelan-Szczerbińska, Beata, et al.
Publicado: (2015)

Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2021)

The Usefulness of Extended Inflammation Parameters and Systemic Inflammatory Response Markers in the Diagnostics of Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2022)

Association of Serum Adiponectin, Leptin, and Resistin Concentrations with the Severity of Liver Dysfunction and the Disease Complications in Alcoholic Liver Disease
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2013)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2021)

Alkaline Phosphatase: The Next Independent Predictor of the Poor 90-Day Outcome in Alcoholic Hepatitis
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2013)

Obesity and novel management of inflammatory bowel disease
por: Kim, Jee Hyun, et al.
Publicado: (2023)

The Impact of Obesity on the Clinical Course of Inflammatory Bowel Disease: A Meta-Analysis
por: Hu, Qiongyuan, et al.
Publicado: (2017)

Indicator of Inflammation and NETosis—Low-Density Granulocytes as a Biomarker of Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2022)

Colorectal carcinoma in the course of inflammatory bowel diseases
por: Hnatyszyn, Andrzej, et al.
Publicado: (2019)

The Occurrence of Gluten-Related Antibodies, Sensitization to Selected Food Allergens, and Antibodies against Intrinsic Factor in Adult Patients with Diarrhea-Predominant Irritable Bowel Syndrome
por: Bierła, Joanna B., et al.
Publicado: (2023)

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2020)

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2023)

Interaction of obesity and inflammatory bowel disease
por: Harper, Jason W, et al.
Publicado: (2016)

Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases
por: Bilski, Jan, et al.
Publicado: (2019)

Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center
por: Choi, David K, et al.
Publicado: (2023)

Can we change the natural course of inflammatory bowel disease?
por: Le Berre, Catherine, et al.
Publicado: (2023)

Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa?
por: Vidal-Lletjós, Sandra, et al.
Publicado: (2017)

Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease
por: Valvano, Marco, et al.
Publicado: (2023)

Antibiotic Resistance and Genotypes of Helicobacter pylori Strains in Patients with Gastroduodenal Disease in Southeast Poland
por: Korona-Glowniak, Izabela, et al.
Publicado: (2019)

Hepatomegaly, weight loss and general malaise – the first manifestations of primary systemic amyloidosis
por: Cichoż-Lach, Halina, et al.
Publicado: (2014)

The Effect of Antidepressants on the Course of Inflammatory Bowel Disease
por: Hall, Barry J., et al.
Publicado: (2018)

Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_re44ee2t6rtckgul9jpmbilcl1